Responsible Translation of Stem Cell Research: An Assessment of Clinical Trial Registration and Publications
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
We assessed the extent to which the publication of clinical trial results of innovative cell-based interventions reflects International Society for Stem Cell Research best practice guidelines. We assessed: (1) characteristics and time to publication of completed trials; (2) quality of reported trials; and (3) results of published trials. We identified and analyzed publications from 1,052 novel stem cell clinical trials: 179 (45.4%) of 393 completed trials had published results; 48 trials were registered by known stem cell tourism clinics, none of which reported results. Completed non-industry-sponsored trials initially published more rapidly, but differences with industry-sponsored trials decreased over time. Most publications reported safety, and 67.3% (mainly early-stage trials) reported positive outcomes. A higher proportion of industry trials reported positive efficacy. Heightened patient expectations for stem cell therapies give rise to ethical obligations for the transparent conduct of clinical trials. Reporting guidelines need to be developed that are specific to early-phase clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessing the quality of controlled clinical trials
Jüni, P., Altman, D. G., & Egger, M. (2001) · BMJ · doi:10.1136/bmj.323.7303.42 · Cited by 3,309 · cited 2×
“The objective of these guidelines is to improve the reporting of randomized trials, which can be subject to bias if they lack methodological rigor (Jüni et al., 2001; Health Canada, 1996).”
BackgroundMoher, D., Hopewell, S., Schulz, K. F., Montori, V., Gøtzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.03.004 · Cited by 1,858
Suñé, P., Suñé, J. M., & Montoro, J. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054583 · Cited by 1,687 · cited 6×
“Not only are positive findings more likely to be published, they are also publishedmore quickly than negative and null findings (Suñé et al., 2013; Hopewell et al., 2009), but positive outcomes are not associated with journal IF (Suñé et al.”
BackgroundResultInfluentialPublication bias in clinical trials due to statistical significance or direction of trial results
Hopewell, S., Loudon, K., Clarke, M. J., Oxman, A. D., & Dickersin, K. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000006.pub3 · Cited by 898 · cited 4×
“Publication Bias Numerous studies have identified a bias toward the publication of positive clinical trial results (Dwan et al., 2014; Hopewell et al., 2009; Vawdrey and Hripcsak, 2013).”
BackgroundInfluentialPublication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis
Ross, J. S., Tse, T., Zarin, D. A., Xu, H., Zhou, L., & Krumholz, H. M. (2012) · BMJ · doi:10.1136/bmj.d7292 · Cited by 371 · cited 9×
“(Jones et al., 2013); a second study reported that 40% of industry and 56% of non-industry-sponsored trials were published from a random sample of trials registered in ClinicalTrials.gov (Ross et al., 2012).”
BackgroundInfluentialNon-publication of large randomized clinical trials: cross sectional analysis
Jones, C. W., Handler, L., Crowell, K. E., Keil, L. G., Weaver, M. A., & Platts-Mills, T. F. (2013) · BMJ · doi:10.1136/bmj.f6104 · Cited by 350 · cited 6×
“(Jones et al., 2013); a second study reported that 40% of industry and 56% of non-industry-sponsored trials were published from a random sample of trials registered in ClinicalTrials.gov (Ross et al., 2012).”
BackgroundResultInfluentialAssessing the Safety of Stem Cell Therapeutics
Goldring, C. E. P., Duffy, P. A., Benvenisty, N., Andrews, P. W., Ben-David, U., Eakins, R., French, N., Hanley, N. A., Kelly, L., Kitteringham, N. R., et al. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.05.012 · Cited by 245
Chen, R., Desai, N. R., Ross, J. S., Zhang, W., Chau, K. H., Wayda, B., Murugiah, K., Lu, D. Y., Mittal, A., & Krumholz, H. M. (2016) · BMJ · doi:10.1136/bmj.i637 · Cited by 227 · cited 2×
“…publication rates of 56.5% for 4,347 interventional trials from academic centers, with 28.6% reporting within 24 months of study completion (Chen et al., 2016); 52% for a cohort of clinical studies approved by the Research Ethics Committee of the University of Freiburg, Germany (Blumle et…”
BackgroundInfluentialDwan, K., Altman, D. G., Clarke, M., Gamble, C., Higgins, J. P. T., Sterne, J. A. C., Williamson, P. R., & Kirkham, J. J. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001666 · Cited by 187 · cited 2×
“Publication Bias Numerous studies have identified a bias toward the publication of positive clinical trial results (Dwan et al., 2014; Hopewell et al., 2009; Vawdrey and Hripcsak, 2013).”
Backgroundvan Gerven, J., & Bonelli, M. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13550 · Cited by 162
Linking ClinicalTrials.gov and PubMed to Track Results of Interventional Human Clinical Trials
Huser, V., & Cimino, J. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068409 · Cited by 90
Publication bias in clinical trials of electronic health records
Vawdrey, D. K., & Hripcsak, G. (2013) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2012.08.007 · Cited by 38
Cited by
Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities
Galipeau, J., & Sensébé, L. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.05.004 · Cited by 1,819
“This criticism often reflects angst arising from the egregiously predatory business activities of unregulated stem cell clinics in the USA and worldwide riding the unproven promise of regenerative therapies, including MSCs, as a cure-all(Turner and Knoepfler, 2016).”
BackgroundInfluentialMesenchymal stromal cells: Putative microenvironmental modulators become cell therapy
Krampera, M., & Le Blanc, K. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2021.09.006 · Cited by 260
Deinsberger, J., Reisinger, D., & Weber, B. (2020) · npj Regenerative Medicine · doi:10.1038/s41536-020-00100-4 · Cited by 158
Bi, X., Ma, B., Liu, W., Gao, W.-Q., Ye, J., & Rao, H. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-04109-0 · Cited by 7
Metadata
- Authors
- Fung, M., Yuan, Y., Atkins, H., Shi, Q., & Bubela, T.
- Venue
- Stem Cell Reports
- Publisher
- Elsevier BV
- Published
- 2017-05
- Volume
- 8
- Issue
- 5
- Pages
- 1190-1201
- ISSN
- 2213-6711 (ISSN-L)
- OpenAlex
- W2606146187
- Cited by
- 78
- References
- 12
- FWCI
- 7.04
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.